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ABSTRACT
Vasopressin and aldosterone play key roles in the
fine adjustment of sodium and water re-absorption
in the nephron. The molecular target of this regula-
tion is the epithelial sodium channel (ENaC) consist-
ing of a-, b- and c-subunits. We investigated
mRNA-specific post-transcriptional mechanisms in
hormone-dependent expression of ENaC subunits in
mouse kidney cortical collecting duct cells.
Transcription experiments and polysome gradient
analysis demonstrate that both hormones act on
transcription and translation. RNA-binding proteins
(RBPs) and mRNA sequence motifs involved in
translational control of c-ENaC synthesis were
studied. c-ENaC–mRNA 30-UTR contains an
AU-rich element (ARE), which was shown by RNA
affinity chromatography to interact with AU-rich
element binding proteins (ARE-BP) like HuR, AUF1
and TTP. Some RBPs co-localized with c-ENaC
mRNA in polysomes in a hormone-dependent
manner. Reporter gene co-expression experiments
with luciferase c-ENaC 30-UTR constructs and
ARE-BP expression plasmids demonstrate the im-
portance of RNA–protein interaction for the
up-regulation of c-ENaC synthesis. We document
that aldosterone and the V2 receptor agonist
dDAVP act on synthesis of a- and c-ENaC subunits
mediated by RBPs as effectors of translation but not
by mRNA stabilization. Immunoprecipitation and
UV-crosslinking analysis of c-ENaC–mRNA/HuR
complexes document the significance of c-ENaC–
mRNA–30-UTR/HuR interaction for hormonal
control of ENaC synthesis.
INTRODUCTION
The epithelial sodium channel (ENaC) consists of the
three subunits a, b and g and is found in the apical
membrane of salt-absorbing epithelia of tissues like
kidney, colon or lung, where it constitutes the rate-limiting
step in Na
+ and water absorption. The number of func-
tional ENaC channels at the cell surface depends on
distinct molecular processes like transcription of the
ENaC genes, synthesis of protein subunits, storage in
vesicles, vesicle traﬃcking and channel assembly in the
membrane and ﬁnally on removal of channels from the
surface by endocytosis and recycling or degradation by
the ubiquitine/proteasome system (for reviews see 1–3).
Synthesis of ENaC subunits is tightly controlled by
hormones responsible for water and salt homoeostasis
like aldosterone, vasopressin or glucocorticoids. The syn-
thesis of a-, b- and g-subunits is not controlled in a
coordinated manner and diﬀers markedly in a tissue-
and development-speciﬁc way. In most cases, there is a
selective change in the levels of one or two subunits, but
rarely in all three (4). For instance, in the rat kidney, al-
dosterone administration leads to an increase in a-ENaC
and not in b- and g-ENaC expression (5). In rat colon,
aldosterone infusion leads to an increase in b- and
g-ENaC, but not in a-ENaC expression (6). An increase
in circulating vasopressin levels results in a selective
increase in the abundance of only b- and g-subunits in
the renal collecting duct (7,8) that was also observed in
cultured mouse cortical collecting duct (CCD) cells (9).
In lung development, the expression of ENaC subunits
changes diﬀerently under the inﬂuence of O2 and gluco-
corticoids during the transition from foetal to the
post-natal stage (10,11).
Basically, hormonal regulation of ENaC expression
is exerted by transcriptional control (9,12–16).
In addition, several studies suggest that mRNA related
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or translational eﬃciency may play an important role
in the synthesis of ENaC subunits (5,17). All studies
agree that both the intracellular and the cell surface
pools of ENaC subunits turn over rapidly with a
half-life in the order of 1–3hr (18). Thus, controlled
ongoing peptide synthesis is a requirement to keep
ENaC in a functional state.
Work on translational control of ENaC expression con-
centrated so far mainly on the role of the 50-untranslated
region (50-UTR) of the a-subunit (10,17,19,20). In contrast
to b- and g-mRNA the a-mRNA contains an unusually
long GC-rich 50-UTR of  550/750nt (rat/human). This
type of 50-UTR is frequently a target for translational
control (21). In rat/mouse and humans diﬀerent tran-
scripts exist with varying lengths of the UTR. The
human 50-UTR, moreover, is prone to alternative
splicing, which leads to a-chains with varying N-termini.
In vitro translation experiments and polysome gradient
analysis revealed that b- and g-ENaC mRNAs are much
more eﬃciently translated than a-mRNA (17). That cor-
relates with an opposite feature of the a-mRNA that
is more abundant than b-o rg-mRNA. Physiological
signiﬁcance of 50-UTR mediated a ENaC translation
control was demonstrated by the action of oxygen
and glucocorticoids in lung development (19). Mecha-
nistically, it was shown that this type of control aﬀects
the 50-cap binding complex and involves phosphoryl-
ation of translation initiation factor eIF4F by mTOR
kinase (20).
mRNA-speciﬁc translational control is not only
mediated by 50- but also by 30-UTRs (22–25). In both 50-
and 30-UTRs cis-elements are found, which interact with
RNA-binding proteins (RBPs) as trans-acting factors
(26,27). In addition to translational eﬃciency metabolic
stability of mRNA is another relevant feature in post-
transcriptional regulation. mRNA stabilization/destabil-
ization is frequently associated with determinants
residing in the 30-UTR. The motifs most intensively
studied are AU-rich elements (AREs), which function by
interaction with ARE-binding proteins (ARE-BPs).
ARE-BPs can mediate mRNA destabilization like
AU-element binding factor 1 (AUF1, synonym hnRNP
D) or tristetraprolin (TTP) and mRNA stabilization by
factors like HuR (synonym ELAV1) (27–29). Some
RBPs like HuR, hnRNP-A1 or nucleolin have also been
shown to be involved in control of translational eﬃciency
(29–31). Examining 30-UTRs of ENaC mRNAs it is
striking that rat, mouse or human g-ENaC mRNAs
contain conserved AU-rich sections that resemble type
III AREs (30).
Here, we investigated post-transcriptional mechanisms
that may operate in regulation of ENaC expression.
We show that up-regulation of a- and g-ENaC by
aldosterone and vasopressin is not only caused by tran-
scription but also by activation of translation, and not by
mRNA stabilization. Mechanistically, the interaction
of RBPs like HuR, TTP or FMRP with an ARE in the




Mouse cortical collecting duct cells (mCCDcl1) were
obtained from the laboratory of B. C. Rossier
(Department of Pharmacology and Toxicology, Faculty
of Biology and Medicine, University of Lausanne,
Lausanne, Switzerland). This highly diﬀerentiated cell
line originates from spontaneous immortalized primary
cells of micro-dissected CCDs from mouse kidneys and
was described previously (32). The cells were grown on
60 cm
2 tissue culture dishes at 37 C and 5% CO2 in a
1:1 mixture of Dulbecco’s modiﬁed Eagle’s medium and
Ham’s F12 medium (DMEM/Ham’s F-12, Biochrom
AG, Berlin, Germany) supplemented with 2% foetal
calf serum (FCS, Biochrom AG, Berlin, Germany),
50U/ml penicillin, 50mg/ml streptomycin (Biochrom
AG, Berlin, Germany), 1mM HEPES-buﬀer (Biochrom
AG, Berlin, Germany), 2mg/ml glucose monohydrate
(Sigma), 1 Insulin-Transferrin-Selenium-G supplement
(Invitrogen-Gibco), 10ng/ml epidermal growth factor
(Sigma), 50nM dexamethasone (Sigma) and 1nM
3,30,5-triiodo-L-thyronin (Sigma). Subsequently this
medium is referred to as ‘growth medium’).
For stimulation experiments cells were seeded on 60 cm
2
tissue culture dishes (TPP AG, Switzerland) and incubated
with growth medium until cells were grown conﬂuent and
began with the formation of domes. Then cells were grown
for 24h in DMEM/Ham’s F12 (Biochrom KG, Berlin,
Germany) supplemented with 2mg/ml Glucose monohy-
drate (Sigma) and 1mM HEPES buﬀer (Biochrom AG,
Berlin, Germany). This medium is subsequently referred
to as ‘stimulation medium’. For stimulation experiments,
cells were incubated for further 24h with stimulation
medium supplemented with either 300nM aldosterone
(32) (Sigma), 10nM dDAVP (33) (Sigma) or 0.1%
Ethanol (Carl Roth) as control.
RNA/protein isolation
For RNA and protein isolation, cells were washed with
ice-cold Dulbecco’s phosphate-buﬀered saline (DPBS).
Total RNA was isolated using RNA-Bee reagent (Biozol
Diagnostica Vertrieb GmbH) according to the manufac-
turer’s protocol. RNA preparation was followed by
DNase digestion with DNaseI (Fermentas) according to
the manufacturer’s protocol, followed by a second RNA
isolation using RNA-Bee reagent (Biozol Diagnostica
Vertrieb GmbH) according to the manufacturer’s
protocol to eliminate all traces of DNase.
For preparation of protein extracts (10000g super-
natants, S10), cell pellets were mixed with 2 volumes
of lysis buﬀer (10mM Tris, pH 7.5, 140mM NaCl,
1mM EDTA, 25% glycerol, 0.1% SDS, 0.5% Nonidet
P-40, 1mM dithiothreitol (DTT), 1 Complete protease
inhibitor mixture; Roche Diagnostics), homogenized
with a Polytron-PT300 blender (Kinematica AG,
Switzerland) and incubated on ice for 20min for lysis.
The homogenate was centrifuged (10min, 4 C, 10000g)
and the supernatant is designated S10. Protein extracts
Nucleic Acids Research, 2010,Vol.38, No. 17 5747were aliquoted, frozen in liquid nitrogen, and stored at
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RT–PCR
First-strand cDNA synthesis was performed with
SuperScript II reverse transcriptase (Invitrogen) and
3mg of total RNA using oligo(dT) primers. mRNA
levels were quantiﬁed by RT–PCR and normalized to
18S/28S rRNA signal in stimulation experiments with
aldosterone or dDAVP. Therefore, 800ng of total RNA
from the RNA used for the RT reaction were run on an
ethidiumbromide agarose gel. This kind of normalization
was veriﬁed by analysing the same samples by northern
blotting. The normalization to stained 18S/28S rRNA
was chosen because of the induction of the normally
used housekeeping genes b-actin and GAPDH under al-
dosterone and dDAVP stimulation. RNA was used for
RT reaction without reverse transcriptase ( RT control)
and was subjected to PCR to verify that there was no
contamination with genomic DNA. There was no contam-
ination in any case that caused a detectable PCR product,
therefore no-RT control is only shown in Figure 10. PCR
conditions were used as follows: 5min at 95 C, cycles were
1min at 95 C, 30s of annealing, 1min at 72 C, ﬁnal elong-









TCAAA. PCR products were separated on 1.5%
agarose gels containing 0.5mg/ml ethidiumbromide.
mRNA stability
To test mRNA stability, mCCDcl1 cells were stimulated
with aldosterone or dDAVP as described above for 24h,
followed by addition of actinomycin D (MoBiTech,
Goettingen, Germany) to a ﬁnal concentration of 10mg/
ml, for inhibition of transcription. After 0, 3, 6, 9 and 24h,
cells were washed twice with ice-cold DPBS and were then
directly harvested with RNA-Bee reagent (Biozol
Diagnostica Vertrieb GmbH). RNA was prepared accord-
ing to the manufacturer’s protocol and estimation of
mRNA concentration was performed by RT–PCR as
described above. To compare the RNA decay under
control conditions with aldosterone and dDAVP stimula-
tion, mRNA levels at the starting point (0h) were referred
to as 100%.
Plasmid constructs
Partial sequences of rat g-ENaC mRNA (GenBank acces-
sion no. NM017046.1) representing the g-ENaC 50-UTR
(98nt) and 30-UTR (933nt) were ampliﬁed by PCR,
cloned and transformed using the TOPO TA Cloning
Dual Promoter Kit (Invitrogen). Positive clones were
veriﬁed by sequencing and used for in vitro transcription.
For the generation of luciferase reporter constructs, the
pGL3-promotor vector (Promega) was modiﬁed as
follows: The vector-speciﬁc 50- and 30-UTRs of luciferase
mRNA were replaced by rat g-ENaC mRNA UTRs or
deletion variants. The UTRs and deletion variants of the
30-UTR were ampliﬁed by PCR from subcloned
pCRII-TOPO constructs and restriction sites were
added by primer extension. The 50-UTR of g-ENaC
mRNA was cloned using the pGL3p vector-speciﬁc
HindIII and NcoI restriction sites and the 30-UTR
(including the poly-A signal) using the XbaI and SalI re-
striction sites. Generation of construct
‘pGL3p-gENaC30-UTRdelAU’ was performed by
deletion of a unique Psi I fragment of the g-ENaC
30-UTR (nt 2869–2958) and religation. Generation of the
construct ‘pGL3p-AU-element’ containing the central
part of the ARE motif (nt 2865–2916) was done by
PCR. The processed vectors were conﬁrmed by
sequencing. The resulting vector constructs expressed a
constitutively transcribed luciferase transcript with or
without the speciﬁc g-ENaC UTRs.
Transfection and luciferase assays
mCCDcl1 cells were grown to  70% conﬂuence in 96-well
plates (mClear Platte 96K, Greiner BIO-ONE GmbH,
Frickenhausen, Germany) and transiently co-transfected
with the ﬁreﬂy luciferase pGL3-promoter vector
(Promega) or the transformed variants containing the
g-ENaC mRNA UTRs or deletion variants and the
‘Renilla’ luciferase phRL-TK vector (Promega). A ratio
(DNA: transfection reagent) of 1:3 was used with the
TransFectin
TM Lipid Reagent (Bio-Rad) according to
the manufacturer’s protocol. Transfection of mCCDcl1
cells with empty pGL3-promoter vector and with the cor-
responding empty expression-vector for co-transfection
experiments served as controls. Co-transfection with the
‘Renilla’ luciferase reporter plasmid was performed for
normalization of transfection eﬃciencies.
For luciferase assays under aldosterone or dDAVP
treatment, cells were set to stimulation medium 24h
after seeding and transfected 30h post-seeding. After
seeding 48h, cells were stimulated by addition of stimula-
tion medium supplemented with either 300nM aldoster-
one (Sigma), 10nM dDAVP (Sigma) or 0.1% ethanol
(Carl Roth) as control.
For co-expression experiments with RBPs, the
following expression vectors and the corresponding
empty vectors were used: pCMV-SPORT6 (empty
vector, Invitrogen), pCMV-SPORT6-HuR, pCMV-
SPORT6-AUF1, pCMV-SPORT6-TTP, pSG5 (empty
vector, Stratagene), pSG5-hnRNP-A1, pEGFP-C1 (BD
Biosciences Clontech), pEGFP-FMRP. The luciferase
activities were measured with a luminometer
(Labsystems Luminoscan RS, Helsinki, Finland)
programmed with individual software (Luminoscan RII,
Ralf Mrowka) 24h after transfection as described (34).
Preparation of polysomes, mRNPs and RNA
Polysomes were obtained from S10 protein extracts by
centrifugation for 2h at 100000g,4  C in a Beckman
SW-41 rotor. The post-polysomal mRNP fraction was
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trifugation for 3h at 300 000g,4  C. Polysomal and mRNP
pellets were dissolved in TKM-buﬀer (50mM Tris, 25mM
KCl, 5mM MgCl2). RNA isolations from polysomes and
RNPs were performed by standard phenol–chloroform
extraction.
Sucrose gradient centrifugation
Cytosolic extracts (S10) of mCCDcl1 cells were layered
onto 11ml of a linear 17–51% sucrose gradient (31)
(0.5–1.5M sucrose, 20mM Tris pH 7.4, 150mM KCl,
5mM MgCl2, 1mM DTT) and centrifuged for 2h at
36000r.p.m. using a Beckman SW-41 rotor. Following
sedimentation, the gradient was fractionated from the
bottom to the top using a peristaltic pump. The ribosomal
proﬁle was determined continuously by measuring absorb-
ance at 254nm using a 2138 UVICORD-S UV monitor
(LKB Bromma). Sucrose gradients were divided into 12
subfractions each, starting with fraction 1 (bottom) to 12
(top). For protein isolation trichloroacetic acid (TCA) was
supplemented to a 10% ﬁnal concentration. Precipitated
proteins were sedimented, washed three times with acetone
and dissolved in 100ml buﬀer (25mM Tris, 1% SDS).
RNA was isolated using the EaZy Nucleic Acid (isolation)
RNA Total Kit (VWR International) according to the
manufacturer’s protocol.
Western blot analysis
Of proteins 20–40mg, for analysis of sucrose gradient frac-
tions 5ml of each fraction, were subjected to 10% SDS–
PAGE and transferred to Roti-PVDF (Roth) by wet
electroblotting using a Bio-Rad Mini Trans-Blot transfer
cell (Bio-Rad). Membranes were blocked by incubation
for 1h in 1 TBS-T (20mM Tris base, 137mM NaCl,
0.1% Tween-20) containing 5% non-fat dried milk (Carl
Roth), followed by incubation with ﬁrst antibody for
either 1h at RT or overnight at 4 C in 1% milk
(1 TBS, 0,1% Tween-20). Membranes were washed
3 for 10min with 1 TBS, 0.1% Tween-20 and
incubated with horseradish peroxidase-conjugated
(HRP-conjugated) secondary antibody for 1h. Then mem-
branes were washed three times for 10min each with
1 TBS, 0.1% Tween-20 and chemo-luminescence was
detected by using ECL plus Western Blotting Detection
System (Amersham Pharmacia Biotech). Membranes were
exposed to ﬁlms (Hyperﬁlm ECL, GE Healthcare) for 1–
5min. For re-probing, membranes were stripped 5–10min
with 0.2M NaOH prior to blocking. The following ﬁrst
antibodies were used for detection: anti-aENaC (E4652,
Sigma) 1:3000, anti-bENaC (sc21013, Santa Cruz) 1:1000,
anti-gENaC (sc22245 santa cruz) 1:500, anti-nucleolin
(ab22758, Abcam) 1:2000, anti-HuR (# 07-468, upstate)
1:1000, anti-AUF1 (# 07-260, upstate) 1:3000, anti
hnRNP-A2/B1 (BM4520, Acris) 1:500, anti-hnRNP-E1
(BioGenes GmbH) 1:12000, anti-annexin (ab41803,
Abcam) 1:1000, anti-ZFP36 (TTP) (ARP34385_P050,
AVIA) 1:1000, anti-FMRP (sc28739, Santa Cruz)
1:1000, anti-hnRNP-A1 (sc10032, Santa Cruz) 1:200,
anti-b-Actin (MAB1501R, Chemicon) 1:4000,
anti-GAPDH (BM429, Acris) 1:6000. As secondary
antibodies following HRP-conjugated antibodies were
used: goat anti-rabbit (sc2030) 1:30000, goat anti-mouse
(sc2031) 1:100000, donkey anti-rabbit (sc2317) 1:10000,
donkey anti-goat (sc2033) 1:10000) and anti-chicken IgY
(G135A, Promega) 1:30000, bovine anti-goat (sc2350)
1:30000. Secondary antibodies were purchased from
Santa Cruz apart anti-chicken IgY. Following antibody
detection western blot membranes were stained with
Coomassie blue and protein bands were used for normal-
ization of western blot signals for all western blots of cyto-
solic extracts under hormone treatment with aldosterone
or dDAVP. This kind of normalization to stained protein
bands was chosen because of the induction of the
normally used housekeeping genes b-actin and GAPDH
under aldosterone and dDAVP stimulation.
RNA aﬃnity chromatography
For the isolation of mRNA-binding proteins, in vitro tran-
scripts representing the 30-UTR of g-ENaC mRNA were
generated in the presence of biotinylated CTP
(Invitrogen). Cytosolic extracts of mCCD cells (40mg
protein) were incubated with 2.5mg in vitro labelled tran-
script for 45min at room temperature. RNP
(ribonucleoprotein) complexes were isolated using 300ml
of streptavidin–agarose/sample (Sigma). Samples without
the addition of biotinylated transcripts served as negative
control. The agarose beads were centrifuged for 2min at
5000g and washed ﬁve times (10mM Tris, pH 7.4, 150mM
KCl, 1.5mM MgCl2, 0.5mM DTT). The last two washing
supernatants were used as control. The RNP complexes
were eluted using two times high salt buﬀer 1 (5 mMTris,
pH 7.4, 1M KCl, 0.75mM MgCl2) and two times high salt
buﬀer 2 (5 mMTris, pH 7.4, 3M KCl, 0.75mM MgCl2).
After combination, proteins were precipitated, dissolved
and subjected to SDS–PAGE. After Coomassie staining,
protein signals representing speciﬁc RNA-binding factors
were excised. Tryptic digestion of proteins was carried out
using ZipPlates (Millipore) without reduction or alkyl-
ation. Tryptic fragments were analysed by Reﬂex IV
matrix assisted laser desorption ionization-time of ﬂight
(MALDI-TOF) mass spectrometer (Bruker-Daltonics).
Mass spectra were analysed using Mascot software 2.0
with automatic search in NCBI non-redundant databases.
Search parameters allowed for one miscleavage and oxi-
dation of methionine. Criteria for positive identiﬁcation of
proteins with MS were set according to the scoring
algorithm.
UV-crosslinking assay
In vitro transcripts representing the 30-UTR of rat g-ENaC
mRNA were radioactively labelled using
[a-32P]uridine-50-triphosphate (800Ci/mmol, MP
Biomedicals GmbH, Heidelberg, Germany). In vitro tran-
scripts were puriﬁed over BD Chroma Spin
TM-100
(DEPC) columns (BD Bioscience). [a-32P]NTP (1–2ng)
labelled in vitro transcript (corresponding to
300000c.p.m.) was incubated with 35mg of cytosolic
protein extract for 30min at room temperature in
10mM Hepes, pH 7.2, 3mM MgCl2, 5% glycerol, 1mM
DTT, 150mM KCl and 2U/ml RNaseOUT (Invitrogen
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ml) as competitor. The samples were exposed to UV light
(255nm, 1.6J, UV-Stratalinker) on ice, followed by
RNase treatment with RNase-A (30mg/ml ﬁnal concentra-
tion) and RNase-T1 (750 U/ml ﬁnal concentration) for 1h
at 37 C and subjected to 12% SDS–PAGE and subse-
quent autoradiography using the Phospho-
Imager-System (Fujiﬁlm FLA-3000).
RNA-pulldown assay
Immunoprecipitation of HuR protein-bound mRNA was
performed using a protocol from Doller et al. (42) with
slight modiﬁcation. Brieﬂy, mCCD cells were stimulated
as described, followed by lysis in a buﬀer containing
10mM HEPES, pH 7.9, 1.5mM MgCl2, 10mM KCl,
0.5mM DTT, 0.1% Nonidet P-40, 50mM NaF, 10mM
Na3VO4, 10mM sodium pyrophosphate, 50mM disodium
glycerol phosphate and 100U/ml RNasin. Subsequently,
cell lysates were immunoprecipitated with 2mg of either a
monoclonal anti-HuR antibody (Santa Cruz) or with the
same amount of mouse IgG (Santa Cruz) as negative
control overnight at 4 C. To normalize for equal input
of RNA before subsequent puriﬁcation steps, the same
amount of extract was subjected to total RNA isolation
as described. Subsequently, protein G-Sepharose CL-4B
beads (Amersham-Biosciences) were added and incubated
for another 2h. After sedimentation of the beads by cen-
trifugation for 5min at 3000g, beads were washed twice
with low salt buﬀer (50mM Tris–HCl, pH 7.5, 150mM
NaCl, 0.2% Triton X-100, 2mM EDTA, 2mM EGTA
and 0.1% SDS) and twice with high salt buﬀer (50mM
Tris–HCl, pH 7.5, 500mM NaCl, 0.2% Triton X-100,
2mM EDTA, 2mM EGTA and 0.1% SDS) before total
RNA was isolated by using RNA-Bee reagent (Biozol
Diagnostica Vertrieb GmbH) as described.
Densitometrical analysis, statistics
Densitometrical analysis of bands from ethidiumbromide
stained agarose gels and autoradiographic western blot
signals was performed by using Scion Image software
(Scion Corp.). If not indicated otherwise, values are pre-
sented as mean±SD. Students’ paired t-test was per-
formed to reveal statistical signiﬁcances. P-values  0.05
were considered signiﬁcant.
RESULTS
Expression of ENaC subunits in mCCD cells under the
action of aldosterone and vasopressin
To study post-transcriptional eﬀects on the synthesis of
ENaC subunits mouse cortical collecting duct cells
(mCCDcl1) expressing functional ENaC channels were
validated to respond to aldosterone and the vasopressin
agonist dDAVP at the mRNA and protein level. As shown
in Figure 1A (mRNA) and B (protein), after 24h,
a marked induction of the a-subunit was observed by al-
dosterone (2.4-fold at the mRNA level, 3.4-fold at the
protein level), but not by dDAVP (0.8 mRNA,
1.1 protein). In contrast, the b-subunit did not
signiﬁcantly respond to aldosterone or to dDAVP (1.1/
1.2 mRNA, 1.1/1.2 protein). The g-subunit, however,
was induced by both, by aldosterone (1.6 mRNA,
1.9 protein) and to a somewhat higher extent by
dDAVP (1.9 mRNA, 2.9 protein).
Distribution of ENaC mRNAs between polysomes and
translational inactive post-polysomal mRNPs
In the cytoplasm of cells, mRNAs reside in two main func-
tional compartments: in a translational active form in
polysomes and in a mainly translational inactive state in
post-polysomal messenger ribonucleoprotein (mRNP)
complexes. To analyse the phenomenon how synthesis of
ENaC subunits is regulated at the mRNA level by
post-transcriptional events, we isolated polysomes and
post-polysomal mRNPs of the cytoplasm of mCCD cells
after cultivation in the presence of aldosterone or dDAVP
by ultracentrifugation (polysomes=100000g pellet of
S10, mRNPs=300000g pellet of S100) and quantiﬁed
ENaC mRNAs by RT–PCR. a-,b-and g-ENaC mRNAs
Figure 1. Inﬂuence of aldosterone and dDAVP on the expression of
ENaC in mCCD cells. mCCD cells were cultivated under control con-
ditions (0.1% ethanol) or in the presence of aldosterone (300nM) or
vasopressin agonist dDAVP (10nM) for 24h. (A) Total RNA was ex-
tracted and relative levels of a-, b- and g-ENaC mRNAs were
quantiﬁed by RT–PCR.  RT controls showed no signals (data not
shown). Values were normalized to 18S rRNA as described in
‘Materials and Methods’ section. Data represent mean ± SD (n=5).
Controls were referred to as 1.0. *P 0.05 compared with control. (B)
In cytosolic extracts (S10) a-, b- and g-ENaC protein was determined
by western blotting and normalized to Coomassie-stained western blot
membranes as described in ‘Materials and Methods’ section. Signals
were quantiﬁed by scanning and densitometrical analysis. Data repre-
sent mean±SD (n=3). Controls were referred to as 1.0. *P 0.05
compared to control.
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cultivated, as well as in aldosterone or dDAVP-treated
cells, a- and b-mRNA were completely associated with
ribosomes and only minor traces were found in the free
mRNP fraction. In opposite, under control conditions,
only  60% of the g-mRNA was associated with poly-
somes, but 40% was found in the translational inactive
free mRNP pool. This ﬁgure changed considerably after
aldosterone or dDAVP treatment. By aldosterone, the
majority of the translational inactive g-ENaC mRNA
shifted into the polysomal fraction and only traces
remained in the mRNP pool. Similarly, also dDAVP ad-
ministration lead to such a shift, but the eﬀect was not as
pronounced as with aldosterone,  10% of the mRNA
remained non-ribosomal associated in the free mRNP
fraction.
c-ENaC mRNA 30-UTR mediates hormonal stimulation
of reporter gene expression
Experiments described in Figure 2 demonstrate that espe-
cially g-ENaC mRNA is characterized by a prominent
change in its intracellular localization (shift from
post-polysomal RNP to polysomal compartment) and its
functional state, presumably by translational activation, in
response to hormone treatment. Therefore the focus was
set on post-transcriptional control of g-ENaC expression.
To substantiate the link between g-ENaC UTR and
hormonal stimulation of ENaC synthesis, luciferase
reporter gene transfection experiments were set up in
mCCD cells, under conditions, where luciferase activity
was dependent on g-ENaC mRNA 50-o r3 0-UTR, or
their combination (Figure 3A). It is obvious that only
g-ENaC 30-UTR was able to mediate translational activa-
tion in aldosterone or dDAVP-treated cells, not however
g-ENaC 50-UTR. Compared to non-hormonal stimulated
cells, 30-UTR enhanced luciferase expression in
aldosterone-treated cells 2.0-fold and in dDAVP-treated
cells 2.3-fold. Although the 50+3 0-UTR combination was
even slightly more eﬀective (aldosterone: 2.1-fold,
dDAVP: 2.9-fold), the 50-UTR itself had no signiﬁcant
inﬂuence.
Characterization of ENaC mRNA stability under the
inﬂuence of aldosterone and vasopressin
One basic mechanism by which gene expression is
modulated post-transcriptionally consists of alteration of
metabolic mRNA stability. This is often mediated by
speciﬁc RBPs interacting with signals in the 30-UTR of
the mRNA (26–28). The 30-UTR of g-ENaC mRNA
contains an AU-rich sequence (Type III ARE,
Figure 3B) in the 30-terminal region, which is highly
conserved between rat and mouse (Figure 3C). Such se-
quences are known to mediate stabilization/destabilization
or translational control by interaction with ARE-BPs.
Figure 3. Eﬀect of aldosterone and dDAVP on expression of luciferase
g-ENaC UTR constructs in mCCD cells. (A) mCCD cells were trans-
fected with the original pGL3p-promoter (pGL3p) vector or chimeric
variants, where original luciferase mRNA 50- and/or 30-UTRs were
substituted by rat g-ENaC 50- and/or 30-UTR. Eighteen-hour
post-transfection cells were incubated for further 24h under control
conditions (without hormone; 0.1% ethanol) or with aldosterone
(300nM) or dDAVP (10nM). UTR-dependent luciferase activity was
measured 24h after stimulation. Transfection eﬃciency was normalized
to expression of co-transfected ‘Renilla’ luciferase and relative values
were related to pGL3p and control (0.1% ethanol). Data represent
mean±SD (n=6). *P 0.05 compared with control. (B) cDNA
sequence of the entire 30-UTR of rat g-ENaC mRNA (Scnn1g,
genbank NM017046) starting with the stop-codon (bold italics) is
shown (nt 2049–2987). The AU-rich region deleted in luciferase
chimeric constructs used for ARE-BP co-expression experiments is
underlined and printed in bold. (C) Alignment of cDNA sequence of
g-ENaC mRNA 30-UTR ARE of rat (NM017046) and mouse
(NM011326).
Figure 2. Distribution of ENaC mRNAs between polysomes and
translational inactive post-polysomal mRNPs. mCCD cells were
cultivated under control conditions (0.1% ethanol), in the presence of
aldosterone (300nM) or dDAVP (10nM) for 24h. Polysomes (100000g
pellet of S10) and post-polysomal mRNP particles (300000g pellet of
S100) were prepared from cytosolic extracts (S10) by ultracentrifuga-
tion, and a-, b- and g-ENaC mRNAs were analysed by RT–PCR.
b-Actin mRNA served as a control. ( RT) controls showed no
signals (data not shown). A representative ﬁgure of three independent
experiments is shown.
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sequences and may be prone to a similar type of control.
Therefore, we analysed the stability of all three ENaC
mRNAs in mCCD cells after inhibition of transcription
by actinomycin D in dependence of aldosterone and
dDAVP action. mRNA levels were observed during 24h
and quantiﬁed by RT–PCR (Figure 4). In no case, the
hormones lead to an increase in mRNA stability. The
results showed furthermore that both hormones did not
contribute to the increase in a-o ri ng-ENaC mRNA con-
centration. In contrast, we observed a slight, but not sig-
niﬁcant, mRNA labilization after actinomycin
D blockade. Using a-amanitin instead of actinomycin
D as transcription inhibitor and performing mRNA
quantiﬁcation by northern blotting lead to similar results
(not shown). Taken together, the increase in a- and
g-mRNA concentration by aldosterone and dDAVP is
not generated by mRNA stabilization, but seems to be
caused by a pure transcriptional mechanism.
Aldosterone and dDAVP are eﬀectors of translational
eﬃciency of ENaC mRNAs
A second mechanism, by which post-transcriptional
control operates, is to facilitate initiation of translation,
which is characterized by enhanced ribosome recruitment
of mRNAs leading subsequently to an enhanced transla-
tional eﬃciency. The resulting increase in the average
polysome size for a speciﬁc mRNA can be characterized
by sedimentation of polysomes through sucrose gradients.
As shown in Figure 5, we performed polysome gradient
analysis with cytosolic lysates (S10) of hormone and
non-hormone treated mCCD cells. The lysates were run
over 17–51% sucrose gradients (Figure 5A), divided in
Figure 4. Stability of ENaC mRNAs in mCCD cells treated with al-
dosterone and dDAVP. Cells were cultivated for 24h in the presence
of 0.1% ethanol (control), 300nM aldosterone or 10nM dDAVP, then
transcription was stopped by addition of actinomycin D (10mM ﬁnal
concentration) and cells were further cultivated for the times indicated.
Total RNA was prepared at each time point and relative levels of a-, b-
and g-ENaC mRNA were quantiﬁed by RT–PCR including b-actin
mRNA as an independent control mRNA. Values were normalized
to 18S/28S rRNA.  RT controls showed no signals (data not
shown). mRNA levels at time point 0h of each condition (control,
aldosterone, dDAVP) was referred to as 100% mRNA remaining for
each transcript. Relative mRNA values of later time points were
calculated referring to the corresponding (same culture condition)
mRNA value at time point 0h. Data represent mean±SD (n=3).
Figure 5. Sucrose polysome gradient analysis: aldosterone and dDAVP
increase translational eﬃciency of a- and g-ENaC mRNA. (A) Equal
amounts of cytosolic extracts of control (0.1% ethanol), aldosterone
(300nM) or dDAVP (10nM) stimulated mCCD cells (S10) were
separated by ultracentrifugation (160000g, 2h, Beckman SW 41
rotor) through 17–51% sucrose gradients and divided into 12 fractions.
Continuous RNA monitoring (OD254) of a representative gradient frac-
tionation from the bottom (51% sucrose) to the top (17% sucrose) is
shown. (B) Total RNA was prepared and relative levels of a-, b- and
g-ENaC mRNAs were monitored by RT–PCR.  RT controls showed
no signals (data not shown). Polysome bound mRNAs sediment in
fractions 2–8, free mRNPs and cytosolic proteins in fractions 9–12.
A representative ﬁgure of three independent experiments is shown.
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were detected by RT–PCR (Figure 5B). The results can
be summarized as follows: a-ENaC mRNA was similarly
present in intermediate-size polysomes under control con-
ditions as in dDAVP-treated cells, but was more eﬃciently
translated in aldosterone-treated cells. The translation
properties of b-ENaC mRNA was neither changed by
dDAVP nor by aldosterone. The ribosome recruitment
of g-ENaC mRNA, however, was enhanced by both
hormones, visible as a shift of the mRNA signal in the
polysomal density proﬁle by two gradient fractions in dir-
ection to heavier polysomes. To check polysome integrity,
parallel gradients were run after EDTA treatment.
As expected, EDTA application lead to a complete dis-
sociation of the polysome complex, detectable as dis-
appearance of the polysome signal in the UV-trace and
a shift of mRNA signals to the top fractions 9–12 of the
gradient (not shown). In conclusion, translational activa-
tion contributes to the induction of a- and g-chains by
aldosterone and V2 receptor stimulation.
Characterization of c-ENaC mRNA-binding RBPs by
RNA aﬃnity chromatography
Important players in post-transcriptional gene regulation
are RBPs. In particular, we were interested in the nature
of potential regulative RBPs and how far their interaction
to motifs in g-ENaC 30-UTR may be changed in response
to hormone action. For the general characterization of
g-ENaC 30-UTR-BPs, we employed RNA aﬃnity chroma-
tography using g-30-UTR as an aﬃnity matrix and mCCD
cell cytoplasm as a source for RBPs. The subsequent iden-
tiﬁcation of candidate proteins was performed by matrix
assisted laser MALDI-TOF mass spectrometry (MS) of
aﬃnity puriﬁed and ﬁnally electrophoretically separated
RBPs. Typically, a pattern of  20–40 Coomassie stainable
polypeptides was obtained. In the example shown, 27 most
prominent bands were subjected to the mass spectroscopic
identiﬁcation procedure (Figure 6). All identiﬁed proteins
out of two (DNA helicase and g-actin) belonged to the
group of RBPs. As discussed above, in g-30-UTR an
ARE is situated in the 30-terminal part (Figure 3B).
Interestingly, among the identiﬁed RBPs, several candi-
dates were found that are discussed as ARE- or general
U-tract binding proteins (annexin II, nucleolin, FMRP,
AUF1, HuR, TTP and hnRNP-A1).
To detect if hormone treatment leads to a signiﬁcant
change in expression of U-tract binding proteins, we
quantiﬁed the candidate ARE-BPs including hnRNP E1
(which was not bound by g-30-UTR) and hnRNP A2/B1
(a close relative to hnRNP A1), as well as non-RBPs
GAPDH and b-actin as controls by western blotting
(Figure 7). As a result, signiﬁcant, but no vast diﬀerences
in the immunological detectable amounts of some analysed
proteins were found. In fact, no diﬀerences existed within
the limits of the methods with annexin II, hnRNP-A1,
hnRNP-E1, nucleolin and TTP. The most signiﬁcant alter-
ationswerebroughtaboutbyaldosterone:aninductionwas
observed with AUF1 (by 30%), FMRP (by 80%) and
hnRNP-A2/B1 (by 70%). The only repression was found
with HuR (by 40%). Remarkably, also the non-RBPs
GAPDH and b-actin used as controls were induced by
aldosterone by  40 and 50%. dDAVP treatment only
lead to a slight induction of two proteins, namely hnRNP
A2/B1 by 20% and HuR by 50%. On the other hand it
evoked a marginal repression by 20–30% of AUF1,
FMRP and hnRNP-E1. The antibody against AUF1
detected four described iso-forms with molecular weights
between 37 and 45kDa (26). There was, however, no
signiﬁcant change in the abundance of the diﬀerent
iso-proteins to each other in the course of hormone
treatment.
Figure 6. Identiﬁcation of cytosolic proteins bound to g-ENaC 30-UTR
by RNA aﬃnity chromatography and MALDI-TOF-MS. RBPs were
puriﬁed by aﬃnity chromatography using biotinylated in vitro tran-
scripts, which represent rat g-ENaC 30-UTR, and cytosolic extracts
(S100) of mCCD cells. Aﬃnity-puriﬁed RBPs were separated by
SDS–PAGE and Coomassie-stained bands were subjected to
MALDI-TOF-MS for protein identiﬁcation. A representative ﬁgure
of three independent experiments is shown.
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As demonstrated above, under hormonal inﬂuence
g-ENaC mRNA was eﬃciently recruited from translation-
al inactive RNPs into polysomes, where protein synthesis
occurs. So we asked, if this shift could be accomplished by
a re-arrangement of mRNA-bound proteins. For this
purpose, we separated the cytoplasm of hormone and
non-hormone-treated cells over sucrose density gradients
as described in Figure 5, divided the gradient into 12 frac-
tions and analysed the same selection of RBPs as shown in
Figure 7 with respect to their polysome association by
western blotting. The results are summarized in
Figure 8. The gradient can be divided into two main
zones: the region of polysomes (bottom region, fractions
2–8) and the region of cytoplasmic proteins including free
mRNPs (top region, fractions 9–12). The following
proteins were found only in free non-polysomal associated
form (fractions 9–12): hnRNP-A2/B1, hnRNP-E1,
nucleolin and the control proteins GAPDH and b-actin.
By contrast, annexin II, AUF1, FMRP, hnRNP-A1, HuR
and TTP were more or less associated with polysomes,
which were occupied by ribosomes to a diﬀerent degree
(fractions 2–8). Interestingly, polysomal association of
certain ARE-BPs changed in response to hormone
action. The most striking alterations were provoked by
aldosterone. AUF1, which was not present in polysomes
under control conditions, became bound, and this applied
only to the two higher molecular weight iso-formes of  42
and 45kDa. Furthermore, FMRP and TTP were increas-
ingly present in larger polysomes of higher translational
eﬃciency. After dDAVP treatment a shift to larger
polysomes, i.e. activation of translational eﬃciency was
only observed with polysomes associated with HuR and
TTP.
Cell transfection co-expression experiments document
signiﬁcance of RBPs in c-ENaC expression
To gain insight into the functional role of RBPs in
g-ENaC post-transcriptional control, luciferase reporter
gene co-expression experiments were performed using
plasmids, containing luciferase coding and complete
g-ENaC 50- and/or 30-UTR sequences. This transfection
was applied in combination with plasmids expressing the
nine selected RBPs described above (Figure 8). The results
are shown in Figure 9. An over-expression of all nine
RBPs had only marginal eﬀects on luciferase expression
when using the basic pGL3p vector (luciferase coding, no
g-ENaC UTRs, 0.8–1.2-fold alteration, not shown).
A distinct alteration of luciferase activity however was
measurable, when RBP plasmids were co-transfected
together with a luciferase construct containing the
g-ENaC 30-UTR. Remarkably, only the ARE-BPs
FMRP, HuR and TTP stimulated reporter gene expres-
sion to a signiﬁcant extent (2.7-, 1.9- and 2.2-fold). AUF1
showed only a slight, non-signiﬁcant eﬀect (1.2-fold stimu-
lation). All stimulatory eﬀects disappeared completely
after deletion of the AU-rich region located in the
30-terminal part of g-ENaC 30-UTR (plasmid
Luc-30-UTRdelAU, see also Figure 3). A very similar
result was obtained with constructs containing the authen-
tic 50+3 0-UTR combination of g-ENaC mRNA. Using this
construct, again FMRP, HuR and TTP stimulated
luciferase expression signiﬁcantly (2.2–3.0-fold) and
Figure 7. Induction of RBPs in mCCD cells by aldosterone and dDAVP. mCCD cells were stimulated with aldosterone or dDAVP as described in
the legend of Figure 1. Thirty micrograms of cytosolic extracts (S10) were analysed for expression of RBPs annexin II, AUF1, FMRP, hnRNP-A1,
hnRNP-A2/B1, hnRNP-E1, HuR, nucleolin, TTP and the controls b-actin and GAPDH by western blotting using speciﬁc antibodies.
(A) Representative western blots of ﬁve independent experiments of the nine RBPs and the two controls are shown. (B) Autoradiographs were
quantiﬁed by scanning and densitometrical analysis. Data represent mean±SD (n=5). *P 0.05 compared to control.
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non-signiﬁcant eﬀects (i.e. hnRNP-A1, -A2/B1 and -E1,
annexin II, and nucleolin; only the data for hnRNP-A1
are shown). To prove that the stimulatory eﬀect was due
to the ARE itself, the central 52nt AU-rich sequence of
the 30-UTR (see Figure 3) was tested in the same way. As
the results show (Figure 9), the isolated ARE had an even
still higher capability to mediate translational activation
by ARE-BPs than the complete 30-UTR (AUF1 2.2-fold,
FMRP 3.4-fold, HuR 2.3-fold and TTP 3.7-fold).
Aldosterone and dDAVP up-regulate c-ENaC expression
by enhanced binding of HuR to c-ENaC mRNA 30-UTR
Polysome association behaviour of g-ENaC mRNA
indicated that aldosterone and dDAVP caused transla-
tional activation of g-ENaC synthesis (Figure 5).
Furthermore, in vitro co-expression experiments using
luciferase/g-ENaC 30-UTR constructs and RBP plasmids
proved that RBPs FMRP, HuR and TTP were able to
activate reporter gene expression in an ARE-dependent
manner (Figure 8). However, this did not prove subse-
quently the in vivo existence of g-ENaC mRNA speciﬁc
mRNP complexes and the functional connection between
hormone action and stimulation of interaction of RBPs
with g-ENaC mRNA. For this reason we applied a
HuR-speciﬁc antibody for immunoprecipitation of HuR
associated polysomes of mCCD cells and analysed the role
of HuR in hormonal stimulation. HuR served as an
example for the analysis of one crucial RBP involved in
post-trancriptional control of g-ENaC expression
(Figure 10A–D).
Western blots demonstrate that an over-expression of
HuR by a factor of  2.0–4.0 over the endogenous level
lead to a concentration dependent increase in g-ENaC
protein in the cytoplasm of  2.5–3.5-fold (Figure 10A).
The result shows that an increase in HuR was suﬃcient to
up-regulate g-ENaC synthesis. To prove that this HuR
dependent up-regulation of g-ENaC was accomplished
by an improved binding of HuR to g-ENaC 30-UTR the
same cytosolic extract was used in UV-crosslinking
analysis. For this purpose
32P-UTP labelled g-ENaC
30-UTR in vitro transcripts were incubated with cytoplasm
containing gradually over-expressed HuR and analysed
for binding. Clearly, a 3–4-fold intensiﬁcation of a signal
migrating at the position of authentic HuR (36kDa) can
be seen (Figure 10B). The supposed ARE binding
sequence is composed of 93% of the nucleotides U+A
and 7% of G+C (Figure 3). If the labelling of the tran-
script was repeated with CTP or GTP instead of UTP
no signal at the 36kDa position was visible, i.e. no
Figure 8. Aldosterone and dDAVP aﬀect binding of RBPs to poly-
somes. Polysomes of hormone-treated mCCD cells were separated
over sucrose gradients and fractionated as described in the legend of
Figure 4. Proteins of each fraction were concentrated by
TCA-precipitation redissolved in a volume of 100ml buﬀer (25mM
Tris, 1% SDS). Proteins of all fractions (5ml) of sucrose gradients
were analysed for RBPs annexin II, AUF1, FMRP, hnRNP-A1,
hnRNP-A2/B1, hnRNP-E1, HuR, nucleolin, TTP and the cytosolic
proteins GAPDH and b-actin by western blotting using speciﬁc
antibodies. A representative ﬁgure of three independent experiments
is shown.
Figure 9. Inﬂuence of over-expressed ARE-BPs on the expression of
chimeric luciferase plasmids containing g-ENaC UTRs. mCCD cells
were transfected with pGL3p vector or chimeric variants, where
original luciferase mRNA UTRs were substituted by rat g-ENaC 30-,
50- and 30-UTR or the 30-UTR deletion variants 30-UTRdelAU
(deletion of base 2869–2958) or AU-element (base 2865–2916) of
g-ENaC mRNA. Furthermore, cells were co-transfected with expres-
sion vectors encoding for proteins of the RBPs hnRNP-A1, AUF1,
FMRP, HuR or TTP. As control cells were co-transfected with
empty expression vector. UTR-dependent luciferase activity was
measured 24h post-transfection. Transfection eﬃciency was normalized
to expression of co-transfected ‘Renilla’ luciferase and relative values
were normalized to the inﬂuence of empty vector control on pGL3p
constructs. Data represent mean±SD (n=6). *P 0.05 compared to
empty vector.
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that the RNA–protein interaction took place predomin-
antly via the nucleotide ‘U’, which is characteristic for
an ARE.
An important strategy to verify the in vivo existence of
g-ENaC–mRNA/HuR complexes is to establish a
co-precipitation pull-down protocol using a HuR speciﬁc
antibody and subsequent isolation of the immune
complexes by protein-G-sepharose. HuR antibody (ab)
bound g-ENaC mRNA was quantiﬁed by RT–PCR. Use
of IgG instead of speciﬁc antibody, as well as quantiﬁca-
tion of unspeciﬁc binding of GAPDH mRNA served as
controls. To assure an equal input, the reaction was
normalized by determination of g-ENaC mRNA prior
to the immune reaction, furthermore PCR controls were
run omitting the RT reaction. Figure 10C describes the
results. It is obvious that the HuR antibody speciﬁcally
precipitated g-ENaC–mRNA/HuR, but not GAPDH–
mRNA/HuR complexes.
This assay was ﬁnally applied to the analysis of mCCD
cells, in which g-ENaC synthesis was stimulated by aldos-
terone or dDAVP before quantiﬁcation of immune
complexes (Figure 10D). As controls served again the
use of unspeciﬁc IgG instead of HuR antibody and deter-
mination of unspeciﬁc GAPDH–mRNA/HuR binding.
An equal protein input in the immune reactions was
guaranteed by electrophoresis and Coomassie blue
staining of an aliquot. It is evident that the increase in
g-ENaC expression by aldosterone or dDAVP action is
reﬂected at the level of mRNP complexes by an increase
in the amount of HuR-bound g-ENaC mRNA (aldoster-
one: 2.5-fold, dDAVP 3.0-fold).
Taken together, immunoprecipitation of g-ENaC–
mRNA/HuR complexes and characterization of the
speciﬁc RNA/protein interaction by UV-crosslinking
document the signiﬁcance of g-ENaC–mRNA–30-UTR/
HuR interaction for hormonal control of ENaC synthesis.
DISCUSSION
We provide several lines of evidence that
post-transcriptional mechanisms operate in hormonal
control of expression of the genes coding for the
subunits of epithelial sodium channel ENaC. This
applies in particular for the a- and g-subunit. We show
that the induction of a- and g-ENaC subunits in mouse
kidney CCD cells by aldosterone and dDAVP is due to
transcription and additionally to activation of mRNA-
speciﬁc translation, not however to mRNA stabilization
(Figures 4 and 5). The increase in ENaC-subunit protein is
partially caused by translational stimulation and is not
solely a result of augmented translation due to risen
mRNA concentration. The well documented potent induc-
tion of the a-subunit by aldosterone (Figure 1) is
accompanied by a signiﬁcant recruitment of the mRNA
by ribosomes (i.e. translational activation) as
demonstrated by polysome gradient analysis. A similar
eﬀect of translational activation was seen with g-ENaC
mRNA responding to both hormones aldosterone and
vasopressin (dDAVP) (Figure 5). As demonstrated
(Figure 2), a substantial part of g-ENaC mRNA is
stored in an untranslated form in the post-polysomal
mRNP compartment until it is activated by hormone
action. The mechanisms, however, by which a- and
g-mRNA were mobilized, seem to diﬀer. Without
hormonal stimulation, g-mRNA persisted to a consider-
able degree at  40% in the translational inactive mRNP
Figure 10. HuR binds to g-ENaC 30-UTR in vitro and to g-ENaC
mRNA in vivo and mediates stimulation of g-ENaC synthesis in a
hormone-dependent way. mCCD cells were transfected for 24h with
5mg of empty vector (mock), 2.5mgo r5 mg of HuR expression vector.
Cells were harvested and HuR over-expression and inﬂuence on en-
dogenous g-ENaC protein was determined by western blotting in cyto-
solic extracts (20mg) using speciﬁc antibodies. Detection of b-actin and
GAPDH served as loading controls (A). The same cytosolic extracts
were subjected to UV-crosslinking assay using
32P-UTP labelled in vitro
transcripts of g-ENaC mRNA 30-UTR and showed an increased
binding capacity for a 36kDa protein (HuR) (B). HuR-bound
mRNA was co-precipitated from cytosolic extracts of mCCD cells
with a HuR-speciﬁc antibody, or alternatively the same amount of
IgG as a negative control. RNA was isolated from last wash fraction
or from antibody-bound (ab-bound) protein-G-sepharose. Isolated
RNA was analysed by RT–PCR using primers for detection of
g-ENaC mRNA or GAPDH mRNA as negative control. Input levels
of g-ENaC mRNA were assessed by RT–PCR, furthermore a PCR
without RT product ( RT) served as negative control (C). The same
immunoprecipitation procedure was repeated with cells pre-treated with
aldosterone or dDAVP (Figure 1) to characterize HuR-association of
g-ENaC mRNA under conditions of hormonal stimulation. RT–PCR
with g-ENaC mRNA speciﬁc primers demonstrated an increase in the
fraction of HuR-bound g-ENaC mRNA in the presence of both
hormones. Equal Input levels of cytosolic extracts were veriﬁed by
SDS–PAGE and Coomassie staining. Negative controls with IgG for
the immunoprecipitation (ip) and detection of GAPDH mRNA in the
ab-bound protein-G-sepharose show the speciﬁcity of the ip reaction
(D). Shown are representative ﬁgures of three independent experiments
each.
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bound mRNA resource was only occupied by ribosomes
to form translational active polysomes during hormonal
stimulation. This is in contrast to the behaviour of the
a-mRNA. With and without hormone treatment the
mRNA was equally complete associated with polysomes.
Thus, the activation process was not elicited by recruiting
the mRNA from a translational inactive mRNP pool, but
it must have proceeded at the polysomal complex itself.
This could for instance result from an enhanced
cap-dependent initiation caused by phosphorylation of
translation initiation factor eIF4F (20). The eﬀect of vaso-
pressin on b-ENaC expression depends considerably on
the model and conditions used. In long-term rat infusion
experiments, the b-subunit is induced like the g-subunit
(7). In cultured rat CCD cells only short-term dDAVP
application (3h) lead to induction of the b-subunit.
After a period of 24h, however, b-ENaC protein
returned to initial levels (9). This corresponds to our ex-
periment achieved with mouse CCD cells (see Figure 1).
A certain discrepancy can be observed if one compares
mRNP associated ENaC mRNAs analysed by direct
particle precipitation (Figure 2) or by sucrose gradient
analysis (Figure 5). In the upper fractions of the sucrose
gradient (mRNP fraction), ENaC mRNA signals are
found that are not present in the 300000g precipates,
which also represent an mRNP fraction. We think this is
due to technical reasons. Whereas precipitation of poly-
somes and mRNPs occurs under RNase protection in
highly concentrated solutions, the sucrose gradients are
run without RNAse protection and the RNA becomes
much more diluted. This could result in a minor RNA
degradation by contaminating RNAses, which shifts
some mRNA fragments to the upper fractions. This
problem can unfortunately not be overcome by adding
RNase inhibitor to the sucrose solution, because during
the run it separates from the polysomal complexes and
remains on top of the gradient.
Important mediators in mRNA-speciﬁc post-
transcriptional control are RBPs interacting with UTRs.
g-ENaC mRNA turned out to be the most interesting
subunit, because it showed under hormone action a con-
spicuous shift in intracellular localization connected with
a remarkable translational activation. g-ENaC mRNA
contains only a short 50-UTR of 69nt (mouse), respective-
ly, 98nt (rat). The 30-UTR is much longer (mouse 931nt,
rat 938nt) and represents a promising target to mediate
post-transcriptional control. Mammalian g-ENaC
mRNAs contain a well conserved AU-rich region in the
30-terminal part of the 30-UTR (mouse: 58nt, A+U
content 90%, rat: 52nt, A+U content 89%, see
Figure 5B) that often serves as a target for the binding
of RBPs involved in stability or translational control (30).
Therefore, we focused our interest on RBP candidates
interacting with g-30-UTR using RNA aﬃnity chromatog-
raphy. RNA aﬃnity chromatography is not a very
speciﬁc, but a helpful, method to narrow down potentially
regulative RBP candidates, because it has the advantage
to allow direct protein identiﬁcation, when combined with
MALDI-TOF-MS (35). Typically, we identiﬁed  20–40
cytosolic polypeptides by this type of experiment. This
is, of course, a certain over-estimation of the number of
proteins, which are expected to interact speciﬁcally with
an mRNA (or UTR, respectively). However, one has to
keep in mind, that also low aﬃnity binders and proteins
are captured, which do not interact directly with the RNA
but keep contact by protein–protein interaction. An
argument for the reliability of the method is the fact
that, among  30 identiﬁed RBPs, only two were found
of other speciﬁcity (Figure 6), i.e. DNA-helicase and
g-actin, which both have a certain capability to bind
also to RNA. Interestingly, several RBPs interacting
with g-30-UTR belonged to the group of ARE-BP.
Therefore, we investigated to which extent the identiﬁed
potential ARE-BPs AUF1, HuR, FMRP, TTP, annexin
II, nucleolin and hnRNP proteins A1 or A2/B1 could be
involved in hormone-mediated g-ENaC translational
control. We approached this problem by testing the fol-
lowing two hypotheses. First, we asked if ARE-BPs were
constitutive components of actively translating polysomes
and if hormones were able to change their qualitative as-
sociation pattern. The result showed that only some RBPs
were associated to polysomes and that only AUF1, HuR,
FMRP and TTP, which belonged to this group, sedi-
mented with heavier, translational more active, polysomes
under the action of aldosterone or dDAVP (Figure 8).
Moreover, aldosterone and dDAVP behaved diﬀerently:
the association of AUF1 and FMRP was altered only by
aldosterone whereas that of HuR was only inﬂuenced by
dDAVP and that of TTP by both hormones.
The other goal was to test the functional signiﬁcance of
RBPs in g-ENaC expression. Therefore, luciferase
reporter genes carrying g-ENaC UTR sequences were
co-expressed together with RBP expression plasmids. As
shown in Figure 9, three of the four selected ARE-BPs
stimulated luciferase expression between 2.2- and
3.0-fold. This was not dependent if the chimeric plasmid
contained also additionally the authentic g-ENaC 50-UTR
(Figure 9A). A simple mechanistic explanation for the
impact of aldosterone and vasopressin on RBP-dependent
g-ENaC translation would result from an induction/re-
pression of RBPs and hence from an altered cytoplasmic
availability. To test this hypothesis, we quantiﬁed nine
RBPs, including AUF1, HuR, FMRP and TTP, by
western blotting in the cytoplasm of hormone treated
CCD cells (Figure 7). Especially in the group of
ARE-BPs, there was a noticeable correlation between
RBP concentration and inﬂuence on translational eﬃ-
ciency (polysome size). For instance, the induction of
AUF1 and FMRP by aldosterone by  30% and 70%,
respectively, corresponded with behaviour of these
proteins to be associated in favour of polysomes of
larger size (Figure 8). Likewise, the induction of HuR by
dDAVP by  50% was found to result in a very similar
eﬀect. The HuR concentration, on the other side, dropped
down slightly under the inﬂuence of aldosterone. From
ARE-BP over-expression experiments similar conclusions
could be drawn (Figure 9). Three co-transfected ARE-BPs
stimulated luciferase expression using chimeric luciferase/
g-ENaC 30-UTR plasmids (HuR, FMRP and TTP).
AUF1, a factor discussed in mRNA destabilization and
translational inhibition, had only marginal eﬀects in
Nucleic Acids Research, 2010,Vol.38, No. 17 5757co-expression experiments (Figure 9), although it was in-
creasingly present in aldosterone-stimulated polysomes
(Figure 8). The behaviour of TTP, on the other side, did
not ﬁt easily into this scheme. Both, aldosterone and
dDAVP did not alter the TTP concentration in the cyto-
plasm, except for a slight, non-signiﬁcant repression by
 5–10%. Nevertheless, under hormone action, TTP was
associated with translational more active polysomes. This,
however, could also result from a change of its binding
properties. TTP is a target of the p38-MAPK/MK2 kinase
cascade and alters its RNA aﬃnity by phosphorylation
(36). Which kinases were activated by the aldosterone
and vasopressin signalling pathways remains to be
investigated. A ﬁrst step could be to determine the phos-
phorylation status of TTP in the context of aldosterone
and vasopressin action using antibodies recognizing
phosphorylated TTP. In the course of g-30-UTR aﬃnity
chromatography another ARE RNA-binding factor was
identiﬁed by MALDI-TOF analysis (Figure 6, gi
14043072). This factor, however, was not investigated in
detail, because no antibody or expression plasmid was
available. In summary, from RNA-binding studies and
reporter gene co-expression experiments it can be
concluded that at least FMRP, HuR and TTP contributed
to hormone mediated up-regulation of g-ENaC synthesis
by 30-UTR dependent translational control.
Although polysome gradient analysis unambiguously
demonstrated that mechanisms of post-transcriptional
control operate in hormonal control of g-ENaC expres-
sion, and in vitro experiments (co-expression of
luciferase-g-ENaC-30-UTR and RBP plasmids) suggested
that an interaction of g-ENaC 30-UTR with certain
ARE-BPs may be involved in this mechanism, only
immunoprecipitation of speciﬁc RNP complexes of
ARE-BPs with g-ENaC mRNA is able to prove this inter-
action in vivo. Following this strategy, we succeeded with
HuR as an example demonstrating its crucial role in
hormonal stimulation of g-ENaC expression in vivo
(Figure 10). The following facts supported our hypothesis:
(i) over-expression of HuR induced g-ENaC synthesis
(10A), (ii) over-expressed HuR associated to
g-ENaC-30-UTR-ARE in a concentration dependent
manner (10B), (iii) a HuR-antibody is able to pull-down
g-ENaC mRNP/polysomes (10C) and (iv) g-ENaC induc-
tion by aldosterone or dDAVP is connected to augmented
formation of g-ENaC–mRNA/HuR complexes proved by
immunoprecipitation (10D). A plausible mechanistic ex-
planation for the improved binding of HuR could be
based on an increase in HuR concentration by the
hormonal stimulus. The mechanism, however, seems to
diﬀer between the two hormones, although the ﬁnal
eﬀect, i.e. the induction of g-ENaC chains, is very
similar. As Figures 8 and 9 demonstrate, dDAVP indeed
induced HuR, and also its association to more active poly-
somes was visible. Aldosterone, on the opposite, slightly
decreased HuR concentration and the polysome associ-
ation was not changed compared to the control.
However, one has to keep in mind that the polysome sedi-
mentation in sucrose gradients reﬂects only the binding
behaviour of HuR to polysomal complexes of all
mRNAs (Figure 8) and not exclusively to speciﬁc
g-ENaC mRNA containing polysomes. But it is tempted
to speculate that the concentration of g-ENaC-speciﬁc
polysomes may have been elevated in contrast to the
overall trend. And indeed, pull-down experiments
showed that the concentration of HuR containing
g-ENaC polysomes increased (Figure 10D) and determin-
ation of speciﬁc g-ENaC mRNA in sucrose gradients
demonstrated that both hormones provoked a favoured
occupation of g-ENaC mRNA with ribosomes
(Figure 5). Recently, a target motif for HuR binding has
been re-evaluated systematically. It constitutes a 17–
20-base long motif rich in uracils that does not necessarily
contain the pentamer AUUUA and rarely C and G. This
motif was found in almost all mRNAs previously reported
to be HuR targets and was preferentially located in
30-UTRs (37). This characteristics ﬁts perfectly to the
g-ENaC-30-UTR ARE (Figure 3).
HuR has been shown to modulate translation by
binding to mRNA 30-UTRs of numerous polypeptides.
This includes examples like tumour suppressor p53 (38),
prothymosin-a (39), cytochrome c (40), CAT-1 (cationic
amino acid transporter) (41), cyclooxygenase-2 (42),
hypoxia inducible factor (HIFa (43) or MKP-1
(mitogen-activated protein kinase phosphatase-1) (44).
The detailed mechanism of HuR/30-UTR-mediated trans-
lational control, however, is poorly understood. As shown
for g-ENaC mRNA, in all cases analysed so far HuR
promoted recruiting of mRNAs to polysomes. In the
case of prothymosin-a UV-stress was associated with
HuR mediated mobilization of target mRNA to the cyto-
plasm and translational activation, demonstrated by shift
to heavier polysomes (39). In post-transcriptional control
of CAT-1 activation HuR triggered a favoured release of
CAT-1 mRNA from cytoplasmic processing bodies and a
relief from miRNA directed translational repression (41).
MPK-1 translational activation by oxidative stress was
also mediated by HuR, which increased the association
of MPK-1 mRNA with the translational machinery (44).
Another scenario applies to mRNAs to which HuR binds
at the 50-UTR and acts as a translational inhibitor. In
IGF-IR (insulin like growth factor receptor) translation
control HuR acts at the 50-UTR as a translational repres-
sor in a cap and internal ribosomal entry sites (IRES)
dependent way (45). Also in the case of p27 (CKI,
cyclin-dependent kinase inhibitor) HuR interacts with an
IRES element thereby inhibiting translation (46).
The regulation of cytoplasmic action of HuR depends
on its phosphorylation, which promotes a shuttle from the
nucleus to the cytoplasm and its binding activity
(42,44,47). Accordingly, two main principles operate in
HuR control, ﬁrst alterations in HuR traﬃcking and
secondly changes in the HuR binding aﬃnity to the
target mRNA in the cytoplasm, in our case g-ENaC
mRNA. Despite the diversity of the mechanisms which
operate in intracellular transport and phosphorylation
they are regulated by some principal signalling
pathways. In the context of HuR phosphorylation the fol-
lowing protein kinases have been described:
mitogen-activated protein kinases (MAPK), AMP
activated kinase (AMPK) and members of the large
family of proteinkinase C (PKC) (28). In the present
5758 Nucleic Acids Research, 2010,Vol.38, No. 17stage of this study, however, it cannot be diﬀerentiated if
alterations in the cytoplasmic HuR concentration of
mCCD cells in the cause of aldosterone or dDAVP
action were due to de novo synthesis, alteration of
protein stability or to an altered export from the
nucleus. Possibly all three principles are involved.
Proteomic studies with inner medullary collecting duct
(cells) or CCD cells demonstrated that aldosterone and
vasopressin signalling cascades are able to alter expression
proﬁles of a large variety of quite diﬀerent proteins (48),
some of them also belonging to the group of RBPs we
studied. But also kinases or phosphatases involved in
HuR phosphorylation/dephosphorylation may be
aﬀected. Factors extensively analysed in ENaC regulation
by aldosterone and vasopressin like SGK1 kinase or
Nedd4 participate in gene activation and protein degrad-
ation (3). How far these and other factors are involved
in synthesis, activation and degradation of HuR and
the other candidate RBPs inﬂuencing g-ENaC mRNA
translation like FMRP and TTP remains to be
determined.
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